Edarbi side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Edarbi. Common side effects include blood pressure decreased among females and fatigue among males.
The phase IV clinical study is created by eHealthMe based on 335 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
335 people who take Edarbi and have side effects are studied.
What is Edarbi?
Edarbi has active ingredients of azilsartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 384 Edarbi users for its effectiveness, alternative drugs and more.
Number of Edarbi reports submitted per year:
Edarbi side effects by time on the drug *:
Edarbi side effects by gender *:
Edarbi side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Edarbi?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on azilsartan medoxomil (the active ingredients of Edarbi) and Edarbi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Edarbi:
- Edarbi (384 reports)
All Edarbi side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.